Schedule 13D ownership disclosure

UROGEN PHARMA LTD

Security class unavailable · CUSIP: M96088105

Event date: 2019-01-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-19-001642
Form type
SC 13D/A
Filer
Arkin Moshe
CIK
CIK 1321178
Filed
Jun 03, 2019
Reporting period
Jan 28, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub